MedDataX Logo

Digital Narrative Bibliotherapy as a Scalable Intervention for Suicidal Thoughts

NCT05351645 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 864

Last updated 2022-04-28

No results posted yet for this study

Summary

The goal of this study was to determine whether reading about others' experiences with suicide can help reduce suicidal thoughts. To investigate this issue, the investigators recruited users from an internet support community. The investigators randomized participants to two separate groups: a Treatment group and a Control group. Participants in the treatment group read one first-person narrative about suicide each day for 14 days, and answered questions before and after reading the narrative. Participants in the Control group answered questions once per day during the 14-day trial period and did not receive the narrative intervention until after the initial study ended. All participants completed a follow-up questionnaire two weeks after the end of the 14-day trial period.

Conditions

  • Suicidal Ideation

Interventions

BEHAVIORAL

Treatment

Once per day for a 14-day trial period, participants in the Treatment group were assigned to read a first-person narrative about a past issue with suicidal thoughts or behaviors. These narratives each contained positive elements, such as providing details about how the author had overcome issues with suicide, suggesting that people with suicidal thought are "not alone," or encouraging people with suicidal thoughts/behaviors to have hope.

Sponsors & Collaborators

  • Harvard University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-20
Primary Completion
2021-03-14
Completion
2021-03-14

Countries

  • United States

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05351645 on ClinicalTrials.gov